These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 3509373

  • 1. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M, Coll R, Esteve M, Parés J, Xicota MA.
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract] [Full Text] [Related]

  • 2. [In vitro evaluation of lomefloxacin].
    Dette GA, Knothe H.
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B, Navarro F, Miró E, Coll R, Xicota MA, Prats G.
    Drugs Exp Clin Res; 1995 Aug; 21(4):129-38. PubMed ID: 8529525
    [Abstract] [Full Text] [Related]

  • 4. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL, Fuchs PC, Brown SD.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [Abstract] [Full Text] [Related]

  • 5. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG, Wang ZQ, Li R, Chen L, Jin XY, Luo SY.
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [Abstract] [Full Text] [Related]

  • 6. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
    Montanari MP, Mingoia M, Varaldo PE.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3616-22. PubMed ID: 11709353
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
    Kwon AR, Min YH, Ryu JM, Choi DR, Shim MJ, Choi EC.
    J Antimicrob Chemother; 2006 Sep; 58(3):684-8. PubMed ID: 16873394
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH, Wang JT, Chen YC, Chang SC, Luh KT.
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A, Ghodsi S, Emami S, Najjari S, Samadi N, Faramarzi MA, Beikmohammadi L, Shirazi FH, Shafiee A.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3499-503. PubMed ID: 16644219
    [Abstract] [Full Text] [Related]

  • 15. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
    Rolston KV, Yadegarynia D, Kontoyiannis DP, Raad II, Ho DH.
    Int J Infect Dis; 2006 May 01; 10(3):223-30. PubMed ID: 16439177
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.
    Prescott JF, Yielding KM.
    Can J Vet Res; 1990 Jan 01; 54(1):195-7. PubMed ID: 2306672
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Chemotherapy; 1992 Jan 01; 38(2):99-106. PubMed ID: 1317282
    [Abstract] [Full Text] [Related]

  • 19. In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
    Marshall SA, Jones RN, Murray PR, Washington JA, Allen SD, Gerlach EH, Erwin ME.
    J Antimicrob Chemother; 1993 Dec 01; 32(6):877-84. PubMed ID: 8144428
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity of E-4441, a representative azetidine quinolone.
    Esteve M, Moros M, Coll R, Xicota MA, Llovera S.
    Drugs Exp Clin Res; 1990 Dec 01; 16(9):445-9. PubMed ID: 2100245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.